Estonia -
Estonia -
Ravimiamet
cestem tablett
ceva sante animale - prasikvanteel+febanteel+püranteel - tablett - 175mg+525mg+175mg 8tk; 175mg+525mg+175mg 4tk
Estonia -
Estonia -
Ravimiamet
panadol suukaudne suspensioon
glaxosmithkline dungarvan limited - paratsetamool - suukaudne suspensioon - 24mg 1ml 100ml 1tk
Estonia -
Estonia -
Ravimiamet
intermec süstelahus
interchemie werken de adelaar eesti aktsiaselts - ivermektiin - süstelahus - 10mg 1ml 50ml 1tk
Estonia -
Estonia -
Ravimiamet
dophexine pulber joogivees/piimas manustamiseks
dopharma research b.v. - broomheksiin - pulber joogivees/piimas manustamiseks - 18,2mg 1g 5000g 1tk; 18,2mg 1g 1000g 1tk
Estonia -
Estonia -
Ravimiamet
alpramil tablett
alfasan nederland b.v. - milbemütsiinoksiim+prasikvanteel - tablett - 12,5mg+125mg 50tk; 12,5mg+125mg 1tk; 12,5mg+125mg 2tk; 12,5mg+125mg 100tk; 12,5mg+125mg 4tk
Estonia -
Estonia -
Ravimiamet
alpramil tablett
alfasan nederland b.v. - milbemütsiinoksiim+prasikvanteel - tablett - 5mg+50mg 25tk; 5mg+50mg 4tk
Estonia -
Estonia -
Ravimiamet
alpramil tablett
alfasan nederland b.v. - milbemütsiinoksiim+prasikvanteel - tablett - 20mg+200mg 40tk; 20mg+200mg 2tk; 20mg+200mg 20tk; 20mg+200mg 4tk; 20mg+200mg 1tk
Kesatuan Eropah -
Estonia -
EMA (European Medicines Agency)
sorafenib accord
accord healthcare s.l.u. - sorafenib tosilate - carcinoma, hepatocellular; carcinoma, renal cell - antineoplastilised ained - hepatocellular carcinomasorafenib accord is indicated for the treatment of hepatocellular carcinoma (see section 5. renal cell carcinomasorafenib accord is indicated for the treatment of patients with advanced renal cell carcinoma who have failed prior interferon-alpha or interleukin-2 based therapy or are considered unsuitable for such therapy.
Estonia -
Estonia -
Ravimiamet
fugasol vet suukaudne lahus
cp-pharma handelsgesellschaft mbh - itrakonasool - suukaudne lahus - 10mg 1ml 25ml 1tk; 10mg 1ml 50ml 1tk
Kesatuan Eropah -
Estonia -
EMA (European Medicines Agency)
livmarli
mirum pharmaceuticals international b.v. - maralixibat chloride - alagille syndrome - other drugs for bile therapy - livmarli is indicated for the treatment of cholestatic pruritus in patients with alagille syndrome (algs) 2 months of age and older.